The investments of 300 million euros will create 180 jobs.
The “BioFuture” plant, which costs 160 million euros, is what they claim to be the world’s most modern plant for the production of therapeutic proteins. A further 140 million euros will be invested in the existing biopharmaceutical plant “Cell Culture 2”. “We are currently investing nowhere more than in Schaftenau,” said Stephen Lang from the Novartis Executive Committee, adding: “The investments are significant for us.”
Tyrol’s governor Günther Platter (ÖVP) emphasized the importance of the industry. These are “highly qualified year-round jobs”.
